Huifeng Bio-Pharmaceutical Technology appoints SVP of Finance

Huifeng Bio-Pharmaceutical Technology, Inc., specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, has appointed Amy Xue to Senior Vice President of Finance.

 

Xue has extensive experience in U.S. GAAP financial reporting and public accounting, and she has performed audit and accounting services for companies in a variety of industries. In 2010, she founded Farolfi & Company, LLC, a New York based accounting and business advisory firm. Prior to that, Xue was a senior manager of Acquavella, Chiarelli, Shuster, Berkower & Co., LLP, a public accounting firm in New York that focuses on SEC audits with Chinese companies.

 

Xue holds a Master's in accounting from Binghamton University and a B.S. in law from Peking University in Beijing, China. She is a U.S. Certified Public Accountant in New York and a member of the American Institute of Certified Public Accountants (AICPA).